WVU Health Pays $4.17 Million After Years of Unreported Drug Diversion

West Virginia United Health System, Inc., doing business as West Virginia University Health System (WVUHS), has agreed to pay the United States $4,177,139⧉ to resolve civil claims that it violated the Controlled Substances Act across 53 DEA-registered hospitals, pharmacies, and clinics -- in West Virginia and neighboring counties of Ohio and Pennsylvania -- from May 8, 2017 through July 18, 2024.▸ Paired with the settlement is a three-year Memorandum of Agreement that does something the DEA's own investigators found WVUHS had never done⧉: make the diversion-control program it built for one city, Morgantown, apply everywhere its 53 registrations operate.

The Drug Enforcement Administration⧉ -- the Justice Department component that licenses and polices every entity legally allowed to handle opioids, stimulants, and other scheduled drugs -- opened this case in May 2022 after receiving an allegation that a single nurse had stolen controlled substances from a WVUHS facility.▸ From there, DEA investigators issued administrative subpoenas, interviewed staff, and inspected records and security measures across the system. What they found went well past one nurse: documentation errors on DEA order forms, thefts and significant losses that went unreported, incomplete inventories, and policies inconsistent with federal recordkeeping rules⧉, spread across facilities that had joined WVUHS at different times between 1996 and 2023.

The recordkeeping violations were only half the finding.▸ Under the Controlled Substances Act, a DEA registrant must report any theft or significant loss of controlled substances in writing within one business day of discovering it⧉ -- that's the rule meant to catch diversion before it becomes routine. WVUHS's own internal investigations turned up thefts going back to January 2017, when a review found a medical provider pulling more Dilaudid than her patient needed, with 'ample evidence' she was diverting narcotics⧉; in February 2018, missing fentanyl and a coworker's tip led to another suspected diversion; in January and March 2021, two more providers were caught, one admitting she'd been stealing 'for a long time,' the other diverting hydrocodone and oxycodone for roughly five years. In each case, WVUHS did not notify the DEA⧉.

WVUHS wasn't blind to the risk.▸ A 2019 report from an outside expert⧉, commissioned by West Virginia University Hospital itself, had already flagged diversion risk at the Morgantown facilities -- including controlled substances that weren't being securely stored -- and hospital leadership knew about the recommendations. Not all of them were carried out. A year earlier, in 2018, WVUHS had stood up a Diversion Response Team, but only at facilities in and around Morgantown⧉. The 2026 agreement now gives WVUHS 180 days to build that same structure -- a systemwide coordinator, a diversion officer at every location, a response team at every location, and an oversight committee -- across all 53 registrations, not just the one city where it started.

The settlement itself is the smaller number.▸ The Memorandum of Agreement requires WVUHS to spend at least $2.5 million installing a minimum of 750 new cameras⧉ at pharmacy and controlled-substance storage sites -- not operating rooms -- by April 2029, on top of the 54 it had already installed since 2019. That $2.5 million camera mandate alone runs to about 60% of the $4,177,139 settlement. It comes stacked on recurring costs WVUHS says it already carries: $500,000 a year in added surveillance staffing it began in 2021⧉ -- before the DEA investigation started -- and $140,000 a year since 2024 for software that flags unusual dispensing patterns⧉. None of that erases the theft: DEA investigators separately found that WVUHS facilities did not consistently notify state licensing boards⧉ when an employee was suspected of diverting drugs, and that some facilities hired staff with a known diversion history.